Abstract
The search for intermediate phenotypes to inform genetic studies of psychiatric disorders is never as productive and exciting as in neuropsychological studies, particularly those of schizophrenia. A variety of cognitive impairments are frequently seen in patients with schizophrenia, and appear to be core features of this illness. In contrast, cognitive impairments seen in other psychiatric disorders, such as depression and mania, are state-related and may not be essential to these disorders (1). In studies of patients with schizophrenia, cognitive impairments do not appear to be caused simply by secondary factors associated with severe mental illness, such as poor cooperation or medications. They are present from an early stage of the illness and are stable over time, suggesting trait-like properties. Furthermore, emerging data suggest, but have not proven, that different profiles of impairment may be present in subgroups of patients. Another feature that makes these cognitive measures attractive targets for genetic studies is that they are closely related to clinical and functional outcome. Thus, the genes underlying cognitive phenotypes may be the most relevant to improving the quality of patients’ lives. Three domains of cognition are generally affected, including working memory/executive function, verbal/declarative memory, and attention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gold J., Goldberg T.E., Kleinman J.E., and Weinberger D.W. (1991) The impact of symptomatic state and pharmacological treatment on cognitive functioning of patients with schizophrenia and mood disorders, in Handbook of Clinical Trials (P M. E. B., ed.), Swets and Zeitlinger, Berwyn, PA, pp. 185–214.
Weickert T. and Golberg T.E. (2000) The course of cognitive impairment in patients with schizophrenia, in New Research in Schizophrenia (PD S. T. H., ed.), Oxford University Press, New York, NY.
Goldberg T. and Green M. Neuropsychology of schizophrenia, in Psychopharmacology, Fifth Generation of Progress (Bloom F.E., Kupfer D., Bunney B. et al., eds.), Lippincott Williams & Wilkins, Philadelphia, PA, in press.
Saykin A.J., Shtasel D.L., Gur R.E., Kester D.B., Mozley L.H., Stafiniak P., et al. (1994) Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psychiatry 51(2), 124–131.
Goldstein G. and Zubin J. (1990) Neuropsychological differences between young and old schizophrenics with and without associated neurological dysfunction. Schizophr. Res. 3, 117–126.
Hyde T., Nawroz S., Goldberg T.E., Bigelow L.B., Strong D., Ostrem J.L., et al. (1994) Is there cognitive decline in schizophrenia? A cross-sectional study. Br. J. Psychiatry 164(4), 494–500.
Goldberg T.E. and Weinberger D.R. (1996) Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies. J. Clin. Psychiatry 57(Suppl. 9), 62–65.
Heaton R.K., Gladsjo J.A., Palmer B. W., Kuck J., Marcotte T.D., and Jeste D.V. (2001) Stability and course of neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry 58(1), 24–32.
Blanchard J. and Neale J.M. (1994) The neuropsychological signature of schizophrenia: generalized or differential deficit? Am. J. Psychiatry 151, 40–48.
Braff D.L., Heaton R., Kuck J., Cullum M., Moranville J., Grant I., et al. (1991) The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch. Gen. Psychiatry 48(10), 891–898.
Shallice T., Burgess P.W., and Frith C.D. (1991) Can the neuropsy chological case-study approach be applied to schizophrenia? Psychol. Med. 21(3), 661–673.
Gold J.M., Hermann B.P., Randolph C., Wyler A.R., Goldberg T.E., and Weinberger D.R. (1994) Schizophrenia and temporal lobe epilepsy. A neuropsychological analysis. Arch. Gen. Psychiatry 51(4), 265–272.
Elvevag B. and Goldberg T.E. (2000) Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 14(1), 1–21.
Weickert T.W., Goldberg T.E., Bigelow L.B., Egan M.F., and Weinberger D.R. (2000) Differential pattern of cognitive impairment in schizophrenic patients with preserved and compromised intellect. Arch. Gen. Psychiatry, in press.
Goldberg T.E., Ragland J.D., Torrey E.F., Gold J.M., Bigelow L.B., and Weinberger D.R. (1990) Neuropsychological assessment of monozygotic twins discordant for schizophrenia (see comments). Arch. Gen. Psychiatry 47(11), 1066–1072.
Goldberg T.E., Torrey E.F., Gold J.M., Ragland J.D., Bigelow L.B., and Weinberger D.R. (1993) Learning and memory in monozygotic twins discordant for schizophrenia. Psychol. Med. 23(1), 71–85.
Goldberg T.E., Torrey E.F., Gold J.M., Bigelow L.B., Ragland R.D., Taylor E., et al. (1995) Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophr. Res. 17(1), 77–84.
Green M.F. (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 15(3), 321–330.
Green M.F., Kern R.S., Braff D.L., and Mintz J. (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophr. Bull. 26(1), 119–136.
Berman K.F., Illowsky B.P., and Weinberger D.R. (1988) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. Arch. Gen. Psychiatry 45(7), 616–622.
Berman K.F., Ostrem J.L., Randolph C., Gold J., Goldberg T.E., Coppola R., et al. (1995) Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia 33(8), 1027–1046.
Berman K.F., Zec R.F., and Weinberger D.R. (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort (see comments). Arch. Gen. Psychiatry 43(2), 126–135.
Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J.P., Duyn J., Coppola R., et al. (2000) Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb. Cortex 10, 1078–1092.
Callicott J.H., Mattay V.S., Bertolino A., Finn K., Coppola R., Frank J.A., et al. (1999) Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb. Cortex 9(1), 20–26.
Weinberger D.R. (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44(7), 660–669.
Weinberger D.R. and Berman K.F. (1988) Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophr. Bull. 14(2), 157–168.
Weinberger D.R., Berman K.F., and Chase T.N. (1988a) Mesocortical dopaminergic function and human cognition. Ann. NY Acad. Sci. 537, 330–338.
Weinberger D.R., Berman K.F., and Illowsky B.P. (1988b) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch. Gen. Psychiatry 45(7), 609–615.
Weinberger D.R., Berman K.F., and Zec R.F. (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 43(2), 114–124.
Aleman A., Hijman R., de Haan E.H., and Kahn R.S. (1999) Memory impairment in schizophrenia: a meta-analysis. Am. J. Psychiatry 156(9), 1358–1366.
Pantelis C., Barber F.Z., Barnes T.R., Nelson H. E., Owen A.M., and Robbins T.W. (1999) Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr. Res. 37(3), 251–270.
Elvevag B., Egan M.F., and Goldberg T.E. (2000a) Memory for temporal order in patients with schizophrenia. Schizophr. Res. 46(2–3), 187–193.
Elvevag B., Egan M.F., and Goldberg T.E. (2000b) Paired associate learning and memory interference in schizophrenia. Neuropsychologia 38(12), 1565–1575.
Paul B., Elvevag B., Bokat C., and Goldberg T.E. (2001) Semantic encoding and episodic memory in schizophrenia.
Elvevag B., Fisher J.E., Gurd J.M., and Goldberg T.E. (2001) Semantic clustering in verbal fluency. (Submitted.)
Elvevag B., Weinberger D.R., Suter J.C., and Goldberg T.E. (2000c) Continuous performance test and schizophrenia: a test of stimulus-response compatibility, working memory, response readiness, or none of the above? Am. J. Psychiatry 157(5), 772–780.
Cannon T.D., Zorrilla L.E., Shtasel D., Gur R.E., Gur R.C., Marco E.J., et al. (1994) Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch. Gen. Psychiatry 51(8), 651–661.
Kremen W.S., Seidman L.J., Pepple J.R., Lyons M.J., Tsuang M.T., and Faraone S.V. (1994) Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr. Bull. 20(1), 103–119.
Fish B. (1977) Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect. Arch. Gen. Psychiatry 34(11), 1297–1313.
Parnas J., Schulsinger F., Schulsinger H., Mednick S.A., and Teasdale T.W. (1982) Behavioral precursors of schizophrenia spectrum. A prospective study. Arch. Gen. Psychiatry 39(6), 658–664.
Cornblatt B.A. and Keilp J.G. (1994) Impaired attention, genetics, and the pathophysiology of schizophrenia [published erratum appears in Schizophr. Bull. 1994;20(2):248]. Schizophr. Bull. 20(1), 31–46.
Nuechterlein K.H. and Dawson M.E. (1984) Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr. Bull. 10(2), 160–203.
Rutschmann J., Cornblatt B., and Erlenmeyer-Kimling L. (1977) Sustained attention in children at risk for schizophrenia. Report on a continuous performance test. Arch. Gen. Psychiatry 34(5), 571–575.
Rutschmann J., Cornblatt B., and Erlenmeyer-Kimling L. (1986) Sustained attention in children at risk for schizophrenia: findings with two visual continuous performance tests in a new sample. J. Abnorm. Child Psychol. 14(3), 365–385.
Asarnow R.F., Steffy R.A., MacCrimmon D.J., and Cleghorn J.M. (1977) An attentional assessment of foster children at risk for schizophrenia. J. Abnorm. Psychol. 86(3), 267–275.
Grunebaum H., Weiss J.L., Gallant D., and Cohler B.J. (1974) Attention in young children of psychotic mothers. Am. J. Psychiatry 131(8), 887–891.
Franke P., Maier W., Hardt J., and Hain C. (1993) Cognitive functioning and anhedonia in subjects at risk for schizophrenia. Schizophr. Res. 10(1), 77–84.
Mirsky A.F., Lochhead S.J., Jones B.P., Kugelmass S., Walsh D., and Kendler K.S. (1992) On familial factors in the attentional deficit in schizophrenia: a review and report of two new subject samples. J. Psychiatr. Res. 26(4), 383–403.
Egan M., Goldberg T.E., Gscheidle T., Weirick, Bigelow L., and Weinberger D.R. (2000) Relative risk of attention deficits in siblings of patients with schizophrenia. Am. J. Psychiatry 157(8), 1309–1316.
Keefe R.S., Silverman J.M., Mohs R.C., Siever L. J., Harvey P.D., Friedman L., et al. (1997) Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia (see comments). Arch. Gen. Psychiatry 54(2), 169–176.
Laurent A., Biloa-Tang M., Bougerol T., Duly D., Anchisi A.M., Bosson J.L., et al. (2000) Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives. Schizophr. Res. 46(2–3), 269–283.
Chen W.J., Liu S.K., Chang C.J., Lien Y.J., Chang Y.H., and Hwu H.G. (1998) Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am. J. Psychiatry 155(9), 1214–1220.
Finkelstein J.R., Cannon T.D., Gur R.E., Gur R.C., and Moberg P. (1997) Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings. J. Abnorm. Psychol. 106(2), 203–212.
Maier W., Franke P., Hain C., Kopp B., and Rist F. (1992) Neuropsychological indicators of the vulnerability to schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 16(5), 703–715.
Saoud M., d’Amato T., Gutknecht C., Triboulet P., Bertaud J.P., Marie-Cardine M., et al. (2000) Neuropsychological deficit in siblings discordant for schizophrenia. Schizophr. Bull. 26(4), 893–902.
Pogue-Geile M.F., Garrett A.H., Brunke J.J., and Hall J.K. (1991) Neuropsychological impairments are increased in siblings of schizophrenic patients. Schizophr. Res. 4 (abstract), 390.
Franke P., Maier W., Hain C., and Klingler T. (1992) Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia? Schizophr. Res. 6(3), 243–249.
Scarone S., Abbruzzese M., and Gambini O. (1993) The Wisconsin Card Sorting Test discriminates schizophrenic patients and their siblings. Schizophr. Res. 10(2), 103–107.
Yurgelun-Todd D.A. and Kinney D.K. (1993) Patterns of neuropsychological deficits that discriminate schizophrenic individuals from siblings and control subjects. J. Neuropsychiatry Clin. Neurosci. 5(3), 294–300.
Shedlack K., Lee G., Sakuma M., Xie S.H., Kushner M., Pepple J., et al. (1997) Language processing and memory in ill and well siblings from multiplex families affected with schizophrenia. Schizophr. Res. 25(1), 43–52.
Condray R. and Steinhauer S.R. (1992) Schizotypal personality disorder in individuals with and without schizophrenic relatives: similarities and contrasts in neurocognitive and clinical functioning. Schizophr. Res. 7, 33–41.
Keefe R.S., Silverman J.M., Roitman S.E., Harvey P.D., Duncan M.A., Alroy D., et al. (1994) Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Res. 53(1), 1–12.
Faraone S.V., Seidman L.J., Kremen W.S., Pepple J.R., Lyons M.J., and Tsuang M.T. (1995) Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. J. Abnorm. Psychol. 104(2), 286–304.
Toomey R., Faraone S.V., Seidman L.J., Kremen W.S., Pepple J.R., and Tsuang M.T. (1998) Association of neuropsychological vulnerability markers in relatives of schizophrenic patients. Schizophr. Res. 31(2–3), 89–98.
Staal W.G., Hijman R., Hulshoff Pol H.E., and Kahn R.S. (2000) Neuropsychological dysfunctions in siblings discordant for schizophrenia. Psychiatry Res. 95(3), 227–235.
Egan M., Goldberg T., Gscheidle T., Bigelow L., Hyde T., and Weinberger D. (2001a) Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol. Psychiatry 50(2), 98–107.
Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., et al. (2001) Working memory impairments in schizophrenic sibships: relative risk estimates and effects of COMT Val108/158Met genotype. submitted.
Byrne M., Hodges A., Grant E., Owens D.C., and Johnstone E.C. (1999) Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS). Psychol. Med. 29(5), 1161–1173.
Park S., Holzman P.S., and Goldman-Rakic P.S. (1995) Spatial working memory deficits in the relatives of schizophrenic patients. Arch. Gen. Psychiatry 52(10), 821–828.
Grove W.M., Lebow B.S., Clementz B.A., Cerri A., Medus C., and Iacono W.G. (1991) Familial prevalence and coaggregation of schizotypy indicators: a multitrait family study. J. Abnorm. Psychol. 100(2), 115–121.
Plomin R., DeFries J.C., and McClearn G.E. (1990) Behavioral Genetics, 2nd ed., W.H. Freeman and Co., New York, NY.
Chen E.Y., Lam L.C., Chen R.Y., Nguyen D.G., Chan C. K., and Wilkins A. J. (1997) Neuropsychological correlates of sustained attention in schizophrenia. Schizophr. Res. 24(3), 299–310.
Goldberg T.E., Torrey E.F., Berman K.F., and Weinberger D.R. (1994) Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophrenia. Psychiatry Res. 556(1), 51–61.
Cannon T.D., Huttunen M.O., Lonnqvist J., Tuulio-Henriksson A., Pirkola T., Glahn D., et al. (2000b) The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am. J. Hum. Genet. 67(2), 369–382.
Kremen W.S., Tsuang M.T., Faraone S.V., and Lyons M. J. (1992) Using vulnerability indicators to compare conceptual models of genetic heterogeneity in schizophrenia. J. Nerv. Ment. Dis. 180(3), 141–152.
Mirsky A.F., Anthony B.J., Duncan C.C., Ahearn M.B., and Kellam S.G. (1991) Analysis of the elements of attention: a neuropsychological approach. Neuropsychology Rev. 2(2), 109–145.
Saudino K.J., Pedersen N.L., and McClearn G.E. (1994) The etiology of high and low cognitive ability during the second half of the life span. Intelligence 19, 359–371.
Cannon T.D., Kaprio J., Lonnqvist J., Huttunen M., and Koskenvuo M. (1998) The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch. Gen. Psychiatry 55(1), 67–74.
Asarnow R.F., Steffy R.A., MacCrimmon D.J., et al. (1978) The McMaster Waterloo project: an attentional and clinical assessment of foster children at risk for schizophrenia, in The Nature of Schizophrenia: New Approaches to Research and Treatment (Wynne L.C., Cromwell R.L., and Matthysse S., eds.), Wiley, New York, NY, pp. 339–358.
Cannon T.D., Bearden C.E., Hollister J.M., Rosso I.M., Sanchez L.E., and Hadley T. (2000a) Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr. Bull. 26(2), 379–393.
Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., et al. (2001b) Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA 98(12), 6917–6922.
Sawaguchi T. and Goldman-Rakic P.S. (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251(4996), 947–950.
Sawaguchi T. and Goldman-Rakic P.S. (1994) The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J. Neurophysiol. 71(2), 515–528.
Seamans J.K., Floresco S.B., and Phillips A.G. (1998) D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J. Neurosci. 18(4), 1613–1621.
Williams G.V. and Goldman-Rakic P.S. (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376(6541), 572–575.
Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. (1996) Human catechol-Omethyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6(3), 243–250.
Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., et al. (1995) Kinetics of human soluble and membranebound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34(13), 4202–4210.
Karoum F., Chrapusta S.J., and Egan M.F. (1994) 3-methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J. Neurochem. 63(3), 972–979.
Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., et al. (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. USA 95(17), 9991–9996.
Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., and Levey A.I. (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 18(7), 2697–2708.
Gasparini M., Fabrizio E., Bonifati V., and Meco G. (1997) Cognitive improvement during Tolcapone treatment in Parkinson’s disease. J. Neural. Transm. 104(8–9), 887–894.
Kneavel M., Gogos J., Karayiorgou K., and Luine V. (2000) Interaction of COMT gene deletion and environment on cognition. Society for Neuroscience 30th Annual Meeting.
Liljequist R., Haapalinna A., Ahlander M., Li Y.H., and Mannisto P.T. (1997) Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav. Brain Res. 82(2), 195–202.
Spielman R.S., McGinnis R.E., and Ewens W.J. (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52(3), 506–516.
Kunugi H., Vallada H.P., Sham P.C., Hoda F., Arranz M.J., Li T., et al. (1997) Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr. Genet. 7(3), 97–101.
Li T., Ball D., Zhao J., Murray R. M., Liu X., Sham P.C., et al. (2000) Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol. Psychiatry 5(1), 77–84.
Li T., Sham P.C., Vallada H., Xie T., Tang X., Murray R.M., et al. (1996) Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr. Genet. 6(3), 131–133.
Weinberger D.R., Aloia M.S., Goldberg T.E., and Berman K.F. (1994) The frontal lobes and schizophrenia. J. Neuropsychiatry Clin. Neurosci. 6(4), 419–427.
Weinberger D.R. (1999) Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry 45(4), 395–402.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Egan, M.F., Goldberg, T.E. (2003). Intermediate Cognitive Phenotypes Associated with Schizophrenia. In: Leboyer, M., Bellivier, F. (eds) Psychiatric Genetics. Methods in Molecular Medicine™, vol 77. Humana Press. https://doi.org/10.1385/1-59259-348-8:163
Download citation
DOI: https://doi.org/10.1385/1-59259-348-8:163
Publisher Name: Humana Press
Print ISBN: 978-1-58829-037-3
Online ISBN: 978-1-59259-348-4
eBook Packages: Springer Protocols